Cargando…

Assessment of disability in idiopathic inflammatory myopathy: a call for linearity

OBJECTIVES: To evaluate the clinimetric properties of the Academic Medical Centre Disability Score (ALDS) in patients with idiopathic inflammatory myopathy (IIM). METHODS: We used prospectively collected data of IIM patients who completed a phase-2 study with first-line IVIG monotherapy. The ALDS is...

Descripción completa

Detalles Bibliográficos
Autores principales:	Min, Minoesch, Walter, Anne W, Lim, Johan, Eftimov, Filip, Verhamme, Camiel, de Visser, Marianne, van Schaik, Ivo N, Aggarwal, Rohit, de Haan, Rob J, van der Kooi, Anneke J, Raaphorst, Joost
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Clinical Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9348770/ https://www.ncbi.nlm.nih.gov/pubmed/34875011 http://dx.doi.org/10.1093/rheumatology/keab906

Ejemplares similares

Intravenous immunoglobulins as first-line treatment in idiopathic inflammatory myopathies: a pilot study
por: Lim, Johan, et al.
Publicado: (2020)

Ultrasound and MR muscle imaging in new onset idiopathic inflammatory myopathies at diagnosis and after treatment: a comparative pilot study
por: Walter, Anne W, et al.
Publicado: (2022)

Pathophysiological Mechanisms and Treatment of Dermatomyositis and Immune Mediated Necrotizing Myopathies: A Focused Review
por: Kamperman, Renske G., et al.
Publicado: (2022)

Treatment with add-on IVIg in Myositis Early In the diSease course May be sUperior to Steroids alone for reaching CLinical improvEment (TIME IS MUSCLE): study protocol of a phase-2 double-blind placebo-controlled randomised trial
por: Kamperman, Renske G, et al.
Publicado: (2023)

OptimisAtion of Diagnostic Accuracy in idioPathic inflammaTory myopathies (ADAPT study): a protocol for a prospective diagnostic accuracy study of multimodality testing in patients suspected of a treatable idiopathic inflammatory myopathy
por: Walter, Hannah A W, et al.
Publicado: (2021)

Oral high dose ascorbic acid treatment for one year in young CMT1A patients: a randomised, double-blind, placebo-controlled phase II trial
por: Verhamme, Camiel, et al.
Publicado: (2009)

B-cell receptor profiling before and after IVIG monotherapy in newly diagnosed idiopathic inflammatory myopathies
por: Anang, Dornatien C, et al.
Publicado: (2022)

Diagnostic value of additional histopathological fascia examination in idiopathic inflammatory myopathies
por: Lim, J., et al.
Publicado: (2019)

Deterioration after corticosteroids in CIDP may be associated with pure focal demyelination pattern
por: Eftimov, Filip, et al.
Publicado: (2014)

PMP22 related neuropathies: Charcot-Marie-Tooth disease type 1A and Hereditary Neuropathy with liability to Pressure Palsies
por: van Paassen, Barbara W, et al.
Publicado: (2014)

Seronegative patients form a distinctive subgroup of immune-mediated necrotizing myopathy
por: Lim, Johan, et al.
Publicado: (2018)

Progression of cognitive and behavioural impairment in early amyotrophic lateral sclerosis
por: Beeldman, Emma, et al.
Publicado: (2020)

Borrelia burgdorferi sensu lato seroconversion after intravenous immunoglobulin treatment: A cohort study
por: Lucke, Ilse M., et al.
Publicado: (2021)

The frontotemporal syndrome of ALS is associated with poor survival
por: Govaarts, Rosanne, et al.
Publicado: (2016)

Brain natriuretic peptide is not predictive of dilated cardiomyopathy in Becker and Duchenne muscular dystrophy patients and carriers
por: Schade van Westrum, Steven, et al.
Publicado: (2013)

Multimodality Screening For (Peri)Myocarditis In Newly Diagnosed Idiopathic Inflammatory Myopathies: A Cross-Sectional Study
por: Lim, Johan, et al.
Publicado: (2023)

Diagnostic challenges in chronic inflammatory demyelinating polyradiculoneuropathy
por: Eftimov, Filip, et al.
Publicado: (2020)

Long-Term Air Pollution Exposure and Amyotrophic Lateral Sclerosis in Netherlands: A Population-based Case–control Study
por: Seelen, Meinie, et al.
Publicado: (2017)

Neurosarcoidosis in a Tertiary Referral Center: A Cross-Sectional Cohort Study
por: Leonhard, Sonja E., et al.
Publicado: (2016)

Late-onset myopathies: clinical features and diagnosis
por: de Visser, Marianne
Publicado: (2020)

Neurofilaments as a plasma biomarker for ICU-acquired weakness: an observational pilot study
por: Wieske, Luuk, et al.
Publicado: (2014)

Paraneoplastic Necrotizing Autoimmune Myopathy in a Patient Undergoing Laparoscopic Pancreatoduodenectomy for Distal Cholangiocarcinoma
por: van Dijk, Stefan, et al.
Publicado: (2016)

Early Prediction of Intensive Care Unit–Acquired Weakness Using Easily Available Parameters: A Prospective Observational Study
por: Wieske, Luuk, et al.
Publicado: (2014)

Impact of ICU-acquired weakness on post-ICU physical functioning: a follow-up study
por: Wieske, Luuk, et al.
Publicado: (2015)

Diagnostic accuracy of quantitative neuromuscular ultrasound for the diagnosis of intensive care unit-acquired weakness: a cross-sectional observational study
por: Witteveen, Esther, et al.
Publicado: (2017)

Cortical and subcortical changes in resting-state neuronal activity and connectivity in early symptomatic ALS and advanced frontotemporal dementia
por: Govaarts, Rosanne, et al.
Publicado: (2022)

Efficacy of a physical activity programme combining individualized aerobic exercise and coaching to improve physical fitness in neuromuscular diseases (I’M FINE): study protocol of a randomized controlled trial
por: Oorschot, Sander, et al.
Publicado: (2020)

Assessing deterioration using impairment and functional outcome measures in chronic inflammatory demyelinating polyneuropathy: A post‐hoc analysis of the immunoglobulin overtreatment in CIDP trial
por: van Veen, Robin, et al.
Publicado: (2022)

Assessment of intensive care unit‐acquired weakness in young and old mice: An E. coli septic peritonitis model
por: Witteveen, Esther, et al.
Publicado: (2015)

No association between gluten sensitivity and amyotrophic lateral sclerosis
por: Visser, Anne E., et al.
Publicado: (2017)

Combined intravenous immunoglobulin and methylprednisolone as induction treatment in chronic inflammatory demyelinating polyneuropathy (OPTIC protocol): a prospective pilot study
por: Adrichem, M. E., et al.
Publicado: (2019)

Repository Corticotropin Injection for Treatment of Idiopathic Inflammatory Myopathies
por: Patel, Aarat, et al.
Publicado: (2016)

Screening for cognition in amyotrophic lateral sclerosis: test characteristics of a new screen
por: Beeldman, Emma, et al.
Publicado: (2021)

Call-duration and triage decisions in out of hours cooperatives with and without the use of an expert system
por: Ong, Rob SG, et al.
Publicado: (2008)

Clinical, genetic, and histological features of centronuclear myopathy in the Netherlands
por: Reumers, Stacha F. I., et al.
Publicado: (2021)

Withdrawal of intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy
por: Adrichem, Max E., et al.
Publicado: (2022)

Role of antifibrotics in the management of idiopathic inflammatory myopathy associated interstitial lung disease
por: Wilfong, Erin M., et al.
Publicado: (2021)

Serum Contactin-1 in CIDP: A Cross-Sectional Study
por: Wieske, Luuk, et al.
Publicado: (2021)

Early Prediction of Intensive Care Unit–Acquired Weakness: A Multicenter External Validation Study
por: Witteveen, Esther, et al.
Publicado: (2018)

Corticosteroids in chronic inflammatory demyelinating polyneuropathy: A retrospective, multicentre study, comparing efficacy and safety of daily prednisolone, pulsed dexamethasone, and pulsed intravenous methylprednisolone
por: van Lieverloo, G. G. A., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_2lvrvsjkr1nvo5p77hnsu0edk6